-
Product Insights
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Propionic Acidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Propionic Acidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Familial Chylomicronemia (Type I Hyperlipoproteinemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Familial Chylomicronemia (Type I Hyperlipoproteinemia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteoporosis Pipeline Drugs Market Overview Osteoporosis signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone fracture that occurs much more easily than expected. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The Osteoporosis pipeline drugs market research report provides an analysis of the Osteoporosis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type....
-
Product Insights
Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Postmenopausal osteoporosis is the most common form of osteoporosis. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. The Post Menopausal Osteoporosis pipeline drugs market research report outlays comprehensive information on the Post Menopausal Osteoporosis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type, that are being developed by companies/universities. It also reviews key players involved in Post Menopausal Osteoporosis targeted therapeutics development...
-
Product Insights
Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pompe disease is an inherited disorder caused by a defect in a gene called GAA. The GAA gene is responsible for the production of the GAA enzyme (acid alpha-glucosidase). The Pompe Disease pipeline drugs market research report outlays comprehensive information on the Pompe Disease targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type, that are being developed by companies/universities. It also reviews key players involved in Pompe Disease...
-
Product Insights
Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The predisposing factors of proliferative diabetic retinopathy include diabetes, high blood pressure, high cholesterol, pregnancy, and tobacco use. Symptoms include spots or dark strings floating in vision, vision loss, fluctuating vision, blurred vision, and difficulty with color perception. Key Targets Integrin Alpha V, Integrin Beta 3, Vascular Endothelial Growth Factor A, DNA (Apurinic or Apyrimidinic Site) Lyase, Integrin Beta 1, Integrin Beta 5, Periostin, and Retinoid Isomerohydrolase Key Mechanism of Actions Integrin Alpha V Antagonist, Integrin Beta 3 Antagonist, Vascular...
-
Product Insights
Hyperuricemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Hyperuricemia include joints becoming swollen, tender, and red, fever, chills, fatigue and kidney problems, or problems with urination. Predisposing factors include age, family history, and certain medications. The Hyperuricemia pipeline drugs market research report provides an overview of the Hyperuricemia (Metabolic Disorders) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperuricemia (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Mitochondrial Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Mitochondrial Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Mitochondrial Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mitochondrial Diseases, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Lipid Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lipid Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lipid Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lipid Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.